Ramitpal K. Basi - 25 Aug 2025 Form 4 Insider Report for INCYTE CORP (INCY)

Signature
/s/ Elizabeth Feeney, Attorney-In-Fact
Issuer symbol
INCY
Transactions as of
25 Aug 2025
Transactions value $
$0
Form type
4
Filing time
27 Aug 2025, 16:43:20 UTC

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Basi Ramitpal K EVP, Human Resources 1801 AUGUSTINE CUT-OFF, WILMINGTON /s/ Elizabeth Feeney, Attorney-In-Fact 27 Aug 2025 0002083591

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INCY Common Stock Award $0 +6.51K $0.00 6.51K 25 Aug 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INCY Performance Shares Award $0 +16.3K $0.00 16.3K 25 Aug 2025 Common Stock 16.3K Direct F3
transaction INCY Employee Stock Option (right to buy) Award $0 +29.2K $0.00 29.2K 25 Aug 2025 Common Stock 29.2K $84.76 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
F2 Includes the August 25, 2025 aggregate grant of 6,506 shares of common stock.
F3 Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
F4 The August 25, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.